ShotBlocker is a non-invasive solution that has been shown to reduce or remove pain in 93.2% of users at half the cost of topical freezing sprays and anaesthetic creams.
The product, pricing and patient analysis found that, over the last six months, intense medicinal cannabis product competition has kept downward pressure on prices.
The AstraZeneca COVID-19 vaccine will no longer be the preferred choice for Australians under the age of 50, due to rare but serious blood clotting side effects.
The approval means that Australians weighing 60 kg and over living with anaphylaxis can now access a 500 mcg adrenaline autoinjector dose.
Avalon Robotics — a joint venture between Avalon SteriTech and SoftBank Robotics Group — will focus on developing innovative products and technologies that benefit public health and wellbeing.
With a tendency to mutate being a hallmark of any pathogen, what can we do to protect ourselves from the threat of more deadly COVID-19 strains?
Oxfam has warned that wealthy countries must facilitate cheaper mass-produced COVID-19 vaccines to protect every person in the world to avert an economic catastrophe.
This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.
In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.
Vaccinating surgical patients ahead of the general population has the potential to help avoid thousands of postoperative deaths linked to the virus.
Callington's Netbiokem DSAM+ Hospital Grade Disinfectant is formulated for use in healthcare facilities for broad-scale infection control.
When choosing a cleaning or disinfection product for a healthcare facility, one of the factors taken into consideration is the compatibility of the product with the equipment or surface.